Cyprus has administered its first dose of the Alzheimer's drug Donanemab, marking the introduction of a treatment designed to slow the progression of the disease in patients diagnosed at an early stage....
A new drug that claims to slow mental decline caused by Alzheimer's by 36 percent could spell 'the beginning of the end' for the degenerative brain disease....
